Salarius Pharmaceuticals, Inc.
Salarius Pharmaceuticals, Inc. (SLRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SLRX · as of Jun 9, 2026
Key Statistics
Explore Salarius Pharmaceuticals, Inc. Data
slrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
slrx competitorsSLRX
ATXI
ENVB
GTBP
INDP
LIPOStock Performance
Full HistoryAbout Salarius Pharmaceuticals, Inc.
Salarius Pharmaceuticals, Inc. is a clinical-stage biotechnology firm dedicated to advancing epigenetic-based cancer therapies. Its flagship investigational product, Seclidemstat (SP-2577), a small mo…
what is salarius pharmaceuticals, inc. · slrx stock overview · salarius pharmaceuticals, inc. company profile · who is salarius pharmaceuticals, inc. ceo · slrx NASDAQ · salarius pharmaceuticals, inc. headquarters · salarius pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Salarius Pharmaceuticals, Inc. (SLRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 29, 2015. As of the latest trading session, SLRX stock price is $0.84, with a market capitalization of $4.9M. The stock has returned -97.21% over the past 12 months and +28.83% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Salarius Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Salarius Pharmaceuticals, Inc. reported revenue of — and net income of -$12.5M. For detailed data — including Salarius Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Salarius Pharmaceuticals, Inc. (SLRX) stock price is $0.84. The stock is traded on NASDAQ under the ticker symbol SLRX. The 52-week range is $0.52 – $52.95.